Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|5|6|445-455

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.5, Iss.6, 2005-09, pp. : 445-455

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of the Human MDR1 Multidrug Transporter

By  

Current Pharmacogenomics, Vol. 2, Iss. 1, 2004-03 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

The Functions and Structure of ABC Transporters: Implications for the Design of New Inhibitors of Pgp and MRP1 to Control Multidrug Resistance (MDR)

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 893-909

Bentham Science Publishers

Access to resources Recommend Favorite

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug Resistance

By  

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 813-821

Bentham Science Publishers

Access to resources Recommend Favorite

MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion

By Lööscher Wolfgang   Delanty Norman  

Pharmacogenomics, Vol. 10, Iss. 5, 2009-05 ,pp. : 711-713

Future Medicine

Access to resources Recommend Favorite

An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 273-286

Bentham Science Publishers

Access to resources Recommend Favorite